BIOMARIN PHARMACEUTICAL INC

Develops and commercializes therapies for rare, life-threatening genetic diseases.

BMRN | US

Overview

Corporate Details

ISIN(s):: US09061G1013
LEI:
Country:: United States of America
Address:: 105 DIGITAL DRIVE, 94949 NOVATO
Website:: https://www.biomarin.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioMarin Pharmaceutical Inc. is a global biotechnology company dedicated to developing and commercializing transformative therapies for rare and life-threatening genetic diseases. Founded in 1997, the company leverages its scientific expertise in the underlying causes of genetic conditions to create first-in-class and best-in-class treatments. Its portfolio of marketed products addresses disorders such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases, often utilizing enzyme replacement therapies (ERTs) and other advanced modalities. BioMarin also maintains an active pipeline of investigational medicines in various stages of clinical and preclinical development to address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOMARIN PHARMACEUTICAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOMARIN PHARMACEUTICAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOMARIN PHARMACEUTICAL INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Novo Nordisk Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.	Denmark	NOVO
NRX Pharmaceuticals, Inc. Develops novel oral drugs for CNS disorders, targeting suicidal depression and PTSD.	United States of America	NRXP
NuCana plc Develops safer anti-cancer medicines with ProTide technology to overcome cell resistance.	United States of America	NCNA
NUFORMIX PLC Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.	United Kingdom	NFX
Nurix Therapeutics, Inc. Developing protein degradation medicines to treat cancer and autoimmune diseases.	United States of America	NRIX
NUTEX Investments Plc Develops & distributes health, cosmetic & pharma products from natural ingredients globally.	Hungary	NUTEX
NutriBand Inc. Develops abuse-deterrent transdermal patches to make potent drug delivery safer.	United States of America	NTRB
Nuvalent, Inc. Designs targeted small molecule drugs for kinase-driven cancers to overcome treatment resistance.	United States of America	NUVL
Nuvation Bio Inc. A clinical-stage biopharma developing novel drugs for difficult-to-treat cancers.	United States of America	NUVB
Nxera Pharma Co., Ltd. Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.	Japan	4565